Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...

The elevated alkaline phosphatase level could be due to mycobacterial ... The patient had abatement of the fever with treatment for mycobacterial infection and hairy-cell leukemia.

Vutrisiran is the generic name for AMVUTTRA ®, which is currently approved in the European Union (EU) for the treatment of ... and increase in blood alkaline phosphatase.

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

KEY POINTS A 22-year-old White man presented to the emergency department with a 2-month history of progressive fatigue, intermittent abdominal pain, constipation, and dyspnea. He had gained 27 kg over ...

Founded on the principles of innovation and patient need, Theriva™ Biologics is a diversified clinical-stage company focused on developing groundbreaking therapeutics to combat cancer and related ...

Winner to be Presented at BIO-Europe 2024 in Stockholm, SwedenROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ ...

GAVRETO is for the treatment of adult patients with metastatic ... calcium (corrected), decreased platelets, increased alkaline phosphatase, increased potassium, decreased potassium, and increased ...

Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high ...